Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Revenue (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Revenue for 9 consecutive years, with $269.1 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 12.25% to $269.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $912.0 million through Dec 2025, up 13.6% year-over-year, with the annual reading at $912.0 million for FY2025, 13.6% up from the prior year.
  • Revenue hit $269.1 million in Q4 2025 for Inspire Medical Systems, up from $224.5 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $269.1 million in Q4 2025 to a low of $40.4 million in Q1 2021.
  • Historically, Revenue has averaged $149.0 million across 5 years, with a median of $152.2 million in 2023.
  • Biggest five-year swings in Revenue: soared 334.7% in 2021 and later grew 10.49% in 2025.
  • Year by year, Revenue stood at $78.4 million in 2021, then surged by 75.9% to $137.9 million in 2022, then soared by 39.6% to $192.5 million in 2023, then rose by 24.52% to $239.7 million in 2024, then grew by 12.25% to $269.1 million in 2025.
  • Business Quant data shows Revenue for INSP at $269.1 million in Q4 2025, $224.5 million in Q3 2025, and $217.1 million in Q2 2025.